LifeLink Ventures is a venture capital firm established in 2020 and based in Barcelona, Spain. The firm specializes in providing private investors access to exclusive investments in the life sciences sector, focusing on early-stage health and biotechnology companies in Europe. LifeLink Ventures seeks out innovative therapies developed by passionate entrepreneurs and aims to connect these ventures with its network of investors. The firm's mission is centered around the strategic deployment of capital to enhance global health outcomes.
Ochre Bio develops genomic medicines to rejuvenate donors' livers before transplant, so that everyone who needs a new liver gets one.
They use genomics to find and shut down over-active genes driving disease and then go directly to testing therapies in discarded donor livers that keep alive outside of the body.
Ochre Bio is within the heart of Oxford’s biotech innovation hub. Their scientific roots can be traced back to over 15 years leading liver genomics research and experience in bringing advanced therapies to market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.